SynovX Recovery 120 C by Xymogen

SynovX Recovery 120 C

Xymogen

$70.99
(No reviews yet) Write a Review
SKU:
XY-JOINT
Availability:
Usually Ships in 48 to 72 Hours
Already Registered?
How to Gain Access to Store?

SynovX Recovery 120 C by Xymogen

SynovX Recovery 120 C is a bone joint health supplement designed by Xymogen, a brand known for transparency and science-backed formulas.* It utilizes clinically studied glucosamine sulfate and chondroitin sulfate, harnessing their synergistic benefits for optimal joint health and function.*

Who Should Consider SynovX Recovery 120 C by Xymogen?

SynovX Recovery 120 C may support your health if you:

  • experience frequent bone joint discomfort*
  • engage in regular physical activity*
  • experience joint health decline due to aging*

SynovX Recovery 120 C—Effects

SynovX Recovery 120 C by Xymogen may have the following effects:

  • supporting bone joint function*
  • supporting proteoglycan synthesis for healthy connective tissue*
  • helping protect your cartilage cells*
  • enhancing post-exercise muscle recovery*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE supplement consultation to learn more about SynovX Recovery 120 C by Xymogen.

Recommendation:
Xymogen suggests taking two capsules twice daily, or as directed by your healthcare professional.

Serving Size: 2 Capsules
Servings Per Container: 60

Amount Per Serving:
Glucosamine Sulfate (as glucosamine sulfate sodium chloride) 750 mg
Chondroitin Sulfate (as chondroitin sulfate sodium)S1 600 mg
Methylsulfonylmethane (MSM) 475 mg

Other Ingredients: Capsule (hypromellose and water), ascorbyl palmitate, medium-chain triglyceride oil, and silica.

Contains: Crustacean shellfish (shrimp and crab).

Does Not Contain: Wheat, gluten, corn, yeast, soy, dairy products, fish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Caution: Consult your healthcare professional prior to use. Individuals taking warfarin or other medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children. Trademarks:
S1. CSBIOACTIVE™ is a trademark licensed by Bioibérica, S.A.U.

Click here to view New Data Sheet

LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited.

References:

  1. Kahan, A., Uebelhart, D., De Vathaire, F., et al. (2009). Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism, 60(2), 524–533. https://doi.org/10.1002/art.24320
  2. Möller, I., Pérez, M., Monfort, J., et al. (2010). Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: A randomized, double-blind, placebo-controlled study. Osteoarthritis and Cartilage, 18(Suppl 1), S32–S40. https://doi.org/10.1016/j.joca.2010.02.018
  3. Wildi, L. M., Raynauld, J. P., Martel-Pelletier, J., et al. (2011). Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: A randomized, double-blind, placebo-controlled pilot study using MRI. Annals of the Rheumatic Diseases, 70(6), 982–989. https://doi.org/10.1136/ard.2010.139386
  4. Hochberg, M. C., & Clegg, D. O. (2008). Potential effects of chondroitin sulfate on joint swelling: A GAIT report. Osteoarthritis and Cartilage, 16(Suppl 3), S22–S24. https://doi.org/10.1016/j.joca.2008.06.014
  5. Adebowale, A., Du, J., Liang, Z., et al. (2002). The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharmaceutics & Drug Disposition, 23(6), 217–225. https://doi.org/10.1002/bdd.320
  6. Tat, S. K., Pelletier, J. P., Mineau, F., et al. (2010). Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage/chondrocytes: Relevance of purity and production process. The Journal of Rheumatology, 37(3), 656–664. https://doi.org/10.3899/jrheum.090556
  7. Barnhill, J. G., Fye, C. L., Williams, W., et al. (2006). Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. Journal of the American Pharmacists Association, 46(1), 14–24. https://doi.org/10.1331/154434506775268822
  8. Glucosamine. (n.d.). Retrieved February 4, 2014, from http://www.naturalstandard.com/databases/herbssupplements/glucosamine.asp
  9. Kelly, G. S. (1998). The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Medicine Review, 3(1), 27–39.
  10. Igarashi, M., Kaga, I., Takamori, Y., et al. (2011). Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes. International Journal of Molecular Medicine, 27(6), 821–827. https://doi.org/10.3892/ijmm.2011.666
  11. Kapoor, M., Mineau, F., Fahmi, H., et al. (2012). Glucosamine sulfate reduces prostaglandin E2 production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1. The Journal of Rheumatology, 39(3), 635–644. https://doi.org/10.3899/jrheum.110815
  12. Largo, R., Alvarez-Soria, M. A., Díez-Ortego, I., et al. (2003). Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 11(4), 290–298. https://doi.org/10.1016/S1063-4584(02)00261-5
  13. Selvan, T., Rajiah, K., Nainar, M. S., et al. (2012). A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis. The Scientific World Journal, 2012, 902676. https://doi.org/10.1100/2012/902676
  14. Tat, S. K., Pelletier, J. P., Vergés, J., et al. (2007). Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: A basic science study. Arthritis Research & Therapy, 9(6), R117. https://doi.org/10.1186/ar2312
  15. Lippiello, L., Woodward, J., Karpman, R., et al. (2000). In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clinical Orthopaedics and Related Research, 381, 229–240. https://doi.org/10.1097/00003086-200012000-00030
  16. Clegg, D. O., Reda, D. J., Harris, C. L., et al. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine, 354(8), 795–808. https://doi.org/10.1056/NEJMoa052771
  17. Fransen, M., Agaliotis, M., Nairn, L., et al. (2014). Glucosamine and chondroitin for knee osteoarthritis: A double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Annals of the Rheumatic Diseases. Advance online publication. https://doi.org/10.1136/annrheumdis-2013-204808
  18. Methylsulfonylmethane (MSM). (2003). Monograph. Alternative Medicine Review, 8(4), 438–441.
  19. Brien, S., Prescott, P., & Lewith, G. (2011). Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee. Evidence-Based Complementary and Alternative Medicine, 2011, 528403. https://doi.org/10.1093/ecam/nen023
  20. Usha, P. R., & Naidu, M. U. (2004). Randomized, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation, 24(6), 353–363. https://doi.org/10.2165/00044011-200424060-00002
  21. Kalman, D. S., Feldman, S., Scheinberg, A. R., et al. (2012). Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: A pilot study. Journal of the International Society of Sports Nutrition, 9(1), 46. https://doi.org/10.1186/1550-2783-9-46
  22. Barmaki, S., Bohlooli, S., Khoshkhahesh, F., et al. (2012). Effect of methylsulfonylmethane supplementation on exercise-induced muscle damage and total antioxidant capacity. Journal of Sports Medicine and Physical Fitness, 52(2), 170–174.